Category: Advanced Clinical

Realising the promise of cancer vaccines

Advanced Clinical, Christopher Oelkrug, Deep Dive, Deep Dive: Oncology, Oncology, Views & Analysis, Views and analysis / July 26, 2022 July 26, 2022

For years, the promise of therapeutic cancer vaccines has intrigued researchers working in the oncology space. And for good reason. The concept of pre-emptively training the immune system to increase the frequencies of tumour-reactive T cells could be game-changing for cancer patients worldwide. Preventative vaccines have already proven to be highly effective against certain cancer …

Realising the promise of cancer vaccines Read More »

Deep Dive: Oncology 2022

Advanced Clinical, AstraZeneca, Daiichi Sankyo, Deep Dive, IQVIA, Oncology, Phesi, syneos health, Views & Analysis, Views and analysis / July 7, 2022 July 7, 2022

Eradicating cancer is an ambitious goal for oncologists and life science companies around the world. But, with a growing number of cancer treatments entering the market each year and dedicated research efforts driving innovation in the sector, there are positive signs that the industry is on the right track. As this issue’s contributors discuss, by …

Deep Dive: Oncology 2022 Read More »

Optimised clinical research through decentralised trials

Advanced Clinical, Caroline Redeker, COVID-19, Deep Dive, Deep Dive: Digital Health 2021, digital, Digital Health 2021, Views & Analysis, Views and analysis / February 1, 2022 February 1, 2022

Not only did the COVID-19 pandemic bring lockdown rules and increased safety protocols, it also led to delays, reconfigurations, limited patient access, and other restrictions for life science research and development. However, one benefit is that it accelerated innovations underway to solve long-standing clinical process issues. “The pandemic turbo-charged trial decentralisation,” says Caroline Redeker, senior …

Optimised clinical research through decentralised trials Read More »

The post-COVID face of pharma research and development

Advanced Clinical, COVID-19, Deep Dive, pandemic, R&D, Research and Development 2021, Views & Analysis, Views and analysis / March 5, 2021 March 5, 2021

The acute phase of the COVID-19 pandemic not only brought delays, restrictions, and reconfigurations to pharmaceutical research & development in 2020, but also a more flexible response to some long-standing issues with the clinical trials process. Lockdown rules and safety protocols certainly made it harder for patients to travel to trial sites, while a refocusing …

The post-COVID face of pharma research and development Read More »